These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Endocervical Adenocarcinoma With Morphologic Features of Both Usual and Gastric Types: Clinicopathologic and Immunohistochemical Analyses and High-risk HPV Detection by In Situ Hybridization. Wada T, Ohishi Y, Kaku T, Aman M, Imamura H, Yasutake N, Sonoda K, Kato K, Oda Y. Am J Surg Pathol; 2017 May; 41(5):696-705. PubMed ID: 28296678 [Abstract] [Full Text] [Related]
6. p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection. Houghton O, Jamison J, Wilson R, Carson J, McCluggage WG. Histopathology; 2010 Sep; 57(3):342-50. PubMed ID: 20727021 [Abstract] [Full Text] [Related]
7. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas. McCluggage WG, Sumathi VP, McBride HA, Patterson A. Int J Gynecol Pathol; 2002 Jan; 21(1):11-5. PubMed ID: 11781517 [Abstract] [Full Text] [Related]
13. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma. McCluggage WG, Oliva E, Herrington CS, McBride H, Young RH. Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729 [Abstract] [Full Text] [Related]
14. [p16 and PR immunoreactivity and human papillomavirus infection in endocervical adenocarcinoma]. Liu X, Li Q, Chen W, Li L, Shen G, Zhang X. Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):263-7. PubMed ID: 24989911 [Abstract] [Full Text] [Related]
16. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Yemelyanova A, Vang R, Seidman JD, Gravitt PE, Ronnett BM. Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407 [Abstract] [Full Text] [Related]
17. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β. Kenny SL, McBride HA, Jamison J, McCluggage WG. Am J Surg Pathol; 2012 Jun; 36(6):799-807. PubMed ID: 22456609 [Abstract] [Full Text] [Related]